Predicting platelet age in an intelligent way

Predicting platelet age in an intelligent way - Predicting platelet age in an intelligent way

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53631

Enrollment

Registered

2023-05-01

Start date

2023-05-01

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low platelet count thrombocytopenia

Interventions

None listed

Eligibility

Age

2 Years to 64 Years

Inclusion criteria

Inclusion criteria: Part 1: Patients diagnosed with Lowe syndrome All ages Part 2: Patients diagnosed with AML After first remission induction (RI) cycle In complete remission after first RI cycle

Exclusion criteria

Exclusion criteria: Part 1: patients with a known bleeding disorder Unwilling to give informed consent Patients using anticoagulants Part 2: patients receiving platelet transfusion in the study period unwilling to give informed consent Patients using anticoagulants

Design outcomes

Primary

Measure	Time frame
For Part 1 as well as Part 2: platelet characteristics using staining of alpha tubulin and VWF and SPARC.	—

Countries

Netherlands

Outcome results